Methacrylic Acid

Methacrylic Acid

SCHEMBL6906597

C=C(C)C(=O)O.C=C(C)C(=O)O.N#CC=CC=Cc1ccccc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
MCL1 Q07820 2/20 0.44
MAOB P27338 3/20 0.44
GLA P06280 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC7 Q8WUI4 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC10 Q969S8 2/20 0.42
HDAC11 Q96DB2 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC9 Q9UKV0 2/20 0.42
HDAC5 Q9UQL6 2/20 0.42
LMNA P02545 4/20 0.40
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL437865 1.00 CYP3A4 (0.46) CYP3A4MCL1MAOBGLATDP1
Methacrylic Acid SCHEMBL28068002 0.98 CYP3A4 (0.45) CYP3A4MCL1MAOBGLATDP1
Methacrylic Acid SCHEMBL863641 0.96 CYP3A4 (0.43) CYP3A4MCL1MAOBGLATDP1
Styrene SCHEMBL7744977 0.94 CYP3A4 (0.46) CYP3A4MCL1MAOBGLATDP1
Methacrylic Acid SCHEMBL1035064 0.93 CYP3A4 (0.41) CYP3A4MCL1MAOBGLATDP1
Methacrylic Acid SCHEMBL28633225 0.89 CYP3A4 (0.45) CYP3A4MCL1MAOBGLATDP1
Styrene SCHEMBL10702189 0.89 CYP3A4 (0.42) CYP3A4MCL1MAOBGLATDP1
SCHEMBL11422112 0.88 GLA (0.47) CYP3A4MCL1MAOBGLATDP1
SCHEMBL9578322 0.87 CYP3A4 (0.41) CYP3A4MCL1MAOBGLATDP1
SCHEMBL440147 0.87 LMNA (0.44) CYP3A4MCL1MAOBGLATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11953650-B2 Sheet and method for producing sheet DAICEL-EVONIK LTD. (JP) 2024-04-09 US disclosed
US-20210231837-A1 SHEET AND METHOD FOR PRODUCING SHEET DAICEL-EVONIK LTD. (JP) 2021-07-29 US disclosed
EP-3812125-A1 SHEET AND METHOD FOR PRODUCING SHEET Daicel-Evonik Ltd. (JP) 2021-04-28 EP disclosed
US-20200230925-A1 LAMINATED BODY AND FLEXIBLE DEVICE PROVIDED WITH SAID LAMINATED BODY DAICEL CORPORATION (JP) 2020-07-23 US disclosed
EP-3659799-A1 LAMINATED BODY AND FLEXIBLE DEVICE PROVIDED WITH SAID LAMINATED BODY Daicel Corporation (JP) 2020-06-03 EP disclosed
US-6828368-B2 Useful for the preparation of a heat-sensitive tacky adhesive having excellent adhesive strength and blocking resistance; solid plasticizer DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2004-12-07 US disclosed
EP-1298121-A1 BIS(CIS-3,3,5-TRIMETHYLCYCLOHEXYL) PHTHALATE, PROCESS FOR PRODUCING THE SAME, AND THERMOPLASTIC RESIN COMPOSITION Daicel Chemical Industries, Ltd. (JP) 2003-04-02 EP disclosed
US-20020193482-A1 Bis(cis-3,3,5-trimethylcyclohexyl) phthalate, process for producing the same, and thermoplastic resin composition DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193482-A1 Bis(cis-3,3,5-trimethylcyclohexyl) phthalate, process for producing the same, and thermoplastic resin composition PSMA3, CDH1, DPY30 CYP3A4 1863/4885MCL1 1421/4885MAOB 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.